U.S. Markets close in 5 hrs 32 mins
  • S&P 500

    4,245.89
    -9.26 (-0.22%)
     
  • Dow 30

    34,256.60
    -137.15 (-0.40%)
     
  • Nasdaq

    14,099.22
    -74.92 (-0.53%)
     
  • Russell 2000

    2,318.21
    -7.93 (-0.34%)
     
  • Crude Oil

    71.80
    +0.92 (+1.30%)
     
  • Gold

    1,861.80
    -4.10 (-0.22%)
     
  • Silver

    27.67
    -0.37 (-1.33%)
     
  • EUR/USD

    1.2129
    +0.0006 (+0.0485%)
     
  • 10-Yr Bond

    1.5060
    +0.0050 (+0.33%)
     
  • Vix

    16.94
    +0.55 (+3.36%)
     
  • GBP/USD

    1.4081
    -0.0027 (-0.1915%)
     
  • USD/JPY

    110.1210
    +0.0600 (+0.0545%)
     
  • BTC-USD

    39,994.10
    -897.00 (-2.19%)
     
  • CMC Crypto 200

    996.49
    -14.11 (-1.40%)
     
  • FTSE 100

    7,175.48
    +28.80 (+0.40%)
     
  • Nikkei 225

    29,441.30
    +279.50 (+0.96%)
     

Four Corners Property Trust Snaps up WellNow Urgent Care Property for $2.3M; Street Says Buy

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Real estate investment trust Four Corners Property Trust (FCPT) has acquired a corporate WellNow Urgent Care facility for a consideration of $2.3 million.

FCPT primarily engages in restaurant properties and the newly acquired urgent care facility is located in a strong retail corridor in New York.

On May 17, FCPT announced the acquisition of Pathway Vet Alliance for $1.8 million.

The Pathway facility is located at a retail corridor with high traffic in Utah. Excluding transaction costs, this acquisition was completed at a 6.7% capitalization rate. (See Four Corners Property Trust stock analysis on TipRanks)

Last month, Raymond James analyst RJ Milligan reiterated a Buy rating on the stock with a price target of $34 (22.5% upside potential).

Milligan commented, “Looking forward, we expect management will adhere to its prudent capital allocation strategy and continue to source creative opportunities that are either off-market or provide more attractive risk-adjusted returns.”

Based on 3 unanimous Buys, consensus among analysts is that FCPT is a Strong Buy. The average analyst price target of $32.33 implies 16.5% upside potential.

Shares have gained about 25% over the past year.

Related News:
Nutanix Posts Smaller-Than-Feared Quarterly Loss, Revenue Beats Estimates
Medtronic Posts a Blowout Quarter as Revenue Outperforms, Bumps up Dividend
Sanofi and GSK Commence Phase 3 Study of COVID-19 Vaccine Candidate

More recent articles from Smarter Analyst: